Expert Opinion on Drug Safety, Volume 17, Issue 3 (2018)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Opinion on Drug Safety, Volume 17, Issue 3 (2018)

See all volumes and issues
Vol 23, 2024 Vol 22, 2023 Vol 21, 2022 Vol 20, 2021 Vol 19, 2020 Vol 18, 2019 Volume 17, 2018 Vol 16, 2017 Vol 15, 2016 Vol 14, 2015 Vol 13, 2014 Vol 12, 2013 Vol 11, 2012 Vol 10, 2011 Vol 9, 2010 Vol 8, 2009 Vol 7, 2008 Vol 6, 2007 Vol 5, 2006 Vol 4, 2005 Vol 3, 2004 Vol 2, 2003 Vol 1, 2002
Download citations Download PDFs Download issue

Review

Review
The role of Iloprost on bone edema and osteonecrosis: Safety and clinical results
Ippokratis Pountos & Peter V Giannoudis
Pages: 225-233
Published online: 23 Jan 2018
AbstractforThe role of Iloprost on bone edema and osteonecrosis: Safety and clinical results | Full Text | References | PDF (906.5 KB)
  • 211 Views
  • 12 CrossRef citations
  • 0Altmetric

Original Research

Article
Twelve weeks of ombitasvir/paritaprevir/r and dasabuvir without ribavirin is effective and safe in the treatment of patients with HCV genotype 1b infection and compensated cirrhosis: results from a real-world cohort study
Esther Chamorro-de-Vega, Alvaro Gimenez-Manzorro, Carmen-Guadalupe Rodriguez-Gonzalez, Vicente Escudero-Vilaplana, Ana De Lorenzo-Pinto, Irene Iglesias-Peinado, Ana Herranz-Alonso, Maria Sanjurjo Saez & on behalf of the GRUviC Study Group
Pages: 235-241
Published online: 11 Jan 2018
AbstractforTwelve weeks of ombitasvir/paritaprevir/r and dasabuvir without ribavirin is effective and safe in the treatment of patients with HCV genotype 1b infection and compensated cirrhosis: results from a real-world cohort study | Full Text | References | PDF (630.4 KB)
  • 153 Views
  • 3 CrossRef citations
  • 0Altmetric

Meta-Analysis

The cardiovascular effect of incretin-based therapies among type 2 diabetes: a systematic review and network meta-analysis
Shanshan Wu, Andrea Cipriani, Zhirong Yang, Jun Yang, Ting Cai, Yang Xu, Xiaochi Quan, Yuan Zhang, Sanbao Chai, Feng Sun & Siyan Zhan
Pages: 243-249
Published online: 10 Jan 2018
AbstractforThe cardiovascular effect of incretin-based therapies among type 2 diabetes: a systematic review and network meta-analysis | Full Text | References | PDF (667.5 KB) | Supplemental
  • 786 Views
  • 21 CrossRef citations
  • 0Altmetric

Review

Review
Anticoagulant and antiplatelet therapy choices for patients with atrial fibrillation one year after coronary stenting or acute coronary syndrome
Christoph B. Olivier, Mintu P. Turakhia & Kenneth W. Mahaffey
Pages: 251-258
Published online: 24 Jan 2018
AbstractforAnticoagulant and antiplatelet therapy choices for patients with atrial fibrillation one year after coronary stenting or acute coronary syndrome | Full Text | References | PDF (806.2 KB)
  • 368 Views
  • 2 CrossRef citations
  • 0Altmetric
Review
Effects of interdisciplinary collaboration in hospitals on medication errors: an integrative review
Elizabeth Manias
Pages: 259-275
Published online: 19 Jan 2018
AbstractforEffects of interdisciplinary collaboration in hospitals on medication errors: an integrative review | Full Text | References | PDF (1.2 MB)
  • 2647 Views
  • 20 CrossRef citations
  • 0Altmetric
Review
The safety of available treatments of male hypogonadism in organic and functional hypogonadism
G. Corona, G. Rastrelli, Y. Reisman, A. Sforza & M. Maggi
Pages: 277-292
Published online: 15 Jan 2018
AbstractforThe safety of available treatments of male hypogonadism in organic and functional hypogonadism | Full Text | References | PDF (1.3 MB)
  • 338 Views
  • 27 CrossRef citations
  • 0Altmetric
Review
A comparative safety review between GLP-1 receptor agonists and SGLT2 inhibitors for diabetes treatment
Agostino Consoli, Gloria Formoso, Maria Pompea Antonia Baldassarre & Fabrizio Febo
Pages: 293-302
Published online: 19 Jan 2018
AbstractforA comparative safety review between GLP-1 receptor agonists and SGLT2 inhibitors for diabetes treatment | Full Text | References | PDF (885.2 KB)
  • 2239 Views
  • 23 CrossRef citations
  • 0Altmetric
Review
An update on the safety of nutraceuticals and effects on lipid parameters
Arrigo F. G. Cicero & Alessandro Colletti
Pages: 303-313
Published online: 29 Jan 2018
AbstractforAn update on the safety of nutraceuticals and effects on lipid parameters | Full Text | References | PDF (964.8 KB)
  • 203 Views
  • 18 CrossRef citations
  • 0Altmetric
Review
Risks and benefits of medications for panic disorder: a comparison of SSRIs and benzodiazepines
Laiana A. Quagliato, Rafael C. Freire & Antonio E. Nardi
Pages: 315-324
Published online: 22 Jan 2018
AbstractforRisks and benefits of medications for panic disorder: a comparison of SSRIs and benzodiazepines | Full Text | References | PDF (905.3 KB)
  • 2183 Views
  • 23 CrossRef citations
  • 0Altmetric

Drug Safety Evaluation

Article
The safety of palbociclib for the treatment of advanced breast cancer
Tom Degenhardt, Rachel Wuerstlein, Tanja Eggersmann & Nadia Harbeck
Pages: 325-330
Published online: 28 Jan 2018
AbstractforThe safety of palbociclib for the treatment of advanced breast cancer | Full Text | References | PDF (464.7 KB)
  • 450 Views
  • 1 CrossRef citations
  • 0Altmetric
Article
The launch of opicapone for Parkinson’s disease: negatives versus positives
Ana Castro Caldas, Tiago Teodoro & Joaquim J Ferreira
Pages: 331-337
Published online: 07 Feb 2018
AbstractforThe launch of opicapone for Parkinson’s disease: negatives versus positives | Full Text | References | PDF (626.8 KB)
  • 326 Views
  • 21 CrossRef citations
  • 0Altmetric

Explore articles